Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9073 |
High Similarity |
NPD3882 |
Suspended |
0.8882 |
High Similarity |
NPD3817 |
Phase 2 |
0.8671 |
High Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.8671 |
High Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8671 |
High Similarity |
NPD6166 |
Phase 2 |
0.8627 |
High Similarity |
NPD1934 |
Approved |
0.8591 |
High Similarity |
NPD6799 |
Approved |
0.8571 |
High Similarity |
NPD2801 |
Approved |
0.8506 |
High Similarity |
NPD6801 |
Discontinued |
0.8462 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8452 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8447 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.8415 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.8415 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.8408 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.8405 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.8397 |
Intermediate Similarity |
NPD5402 |
Approved |
0.8355 |
Intermediate Similarity |
NPD1512 |
Approved |
0.8354 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.8333 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8302 |
Intermediate Similarity |
NPD5494 |
Approved |
0.8301 |
Intermediate Similarity |
NPD5403 |
Approved |
0.8301 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.8293 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.8282 |
Intermediate Similarity |
NPD7054 |
Approved |
0.8261 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.8258 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.8243 |
Intermediate Similarity |
NPD2796 |
Approved |
0.8232 |
Intermediate Similarity |
NPD7472 |
Approved |
0.8232 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.8224 |
Intermediate Similarity |
NPD1511 |
Approved |
0.8171 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.817 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.817 |
Intermediate Similarity |
NPD5401 |
Approved |
0.8146 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.8141 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.8137 |
Intermediate Similarity |
NPD1247 |
Approved |
0.8133 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.8125 |
Intermediate Similarity |
NPD919 |
Approved |
0.8092 |
Intermediate Similarity |
NPD6190 |
Approved |
0.8067 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.8067 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.8063 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7987 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7973 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7952 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7945 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7933 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7905 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7891 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7875 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7866 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7862 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7831 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7826 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7821 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7818 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7808 |
Intermediate Similarity |
NPD9494 |
Approved |
0.78 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7756 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7727 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7716 |
Intermediate Similarity |
NPD5353 |
Approved |
0.7711 |
Intermediate Similarity |
NPD5242 |
Approved |
0.7702 |
Intermediate Similarity |
NPD37 |
Approved |
0.7697 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7679 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7677 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7669 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7669 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7669 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7667 |
Intermediate Similarity |
NPD943 |
Approved |
0.7667 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7667 |
Intermediate Similarity |
NPD1613 |
Approved |
0.766 |
Intermediate Similarity |
NPD5536 |
Phase 2 |
0.7655 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.764 |
Intermediate Similarity |
NPD6385 |
Approved |
0.764 |
Intermediate Similarity |
NPD6386 |
Approved |
0.7628 |
Intermediate Similarity |
NPD3887 |
Approved |
0.7616 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7602 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.759 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7582 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7574 |
Intermediate Similarity |
NPD2163 |
Approved |
0.7548 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7545 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7534 |
Intermediate Similarity |
NPD2982 |
Phase 2 |
0.7534 |
Intermediate Similarity |
NPD2983 |
Phase 2 |
0.7532 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7532 |
Intermediate Similarity |
NPD4357 |
Discontinued |
0.7529 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7484 |
Intermediate Similarity |
NPD3688 |
Clinical (unspecified phase) |
0.7484 |
Intermediate Similarity |
NPD3146 |
Approved |
0.7483 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.747 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7466 |
Intermediate Similarity |
NPD2981 |
Phase 2 |
0.7456 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7453 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7452 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.745 |
Intermediate Similarity |
NPD3018 |
Phase 2 |
0.7417 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7405 |
Intermediate Similarity |
NPD2354 |
Approved |
0.74 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.74 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7391 |
Intermediate Similarity |
NPD920 |
Approved |
0.7386 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7386 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7386 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7376 |
Intermediate Similarity |
NPD1241 |
Discontinued |
0.7372 |
Intermediate Similarity |
NPD2353 |
Approved |
0.7372 |
Intermediate Similarity |
NPD2355 |
Clinical (unspecified phase) |
0.7368 |
Intermediate Similarity |
NPD4062 |
Phase 3 |
0.7355 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7349 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7347 |
Intermediate Similarity |
NPD3972 |
Approved |
0.7347 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7341 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7333 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7322 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7318 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.731 |
Intermediate Similarity |
NPD9268 |
Approved |
0.7308 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7308 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7308 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7305 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7299 |
Intermediate Similarity |
NPD7038 |
Approved |
0.7299 |
Intermediate Similarity |
NPD7039 |
Approved |
0.7278 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7278 |
Intermediate Similarity |
NPD2800 |
Approved |
0.7267 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7267 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7267 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7267 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7267 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7267 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7261 |
Intermediate Similarity |
NPD2344 |
Approved |
0.726 |
Intermediate Similarity |
NPD17 |
Approved |
0.7253 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7251 |
Intermediate Similarity |
NPD7784 |
Clinical (unspecified phase) |
0.725 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7246 |
Intermediate Similarity |
NPD5019 |
Clinical (unspecified phase) |
0.7244 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7241 |
Intermediate Similarity |
NPD9545 |
Approved |
0.7233 |
Intermediate Similarity |
NPD4110 |
Phase 3 |
0.7233 |
Intermediate Similarity |
NPD4109 |
Clinical (unspecified phase) |
0.723 |
Intermediate Similarity |
NPD9269 |
Phase 2 |
0.7195 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7176 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.7171 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7162 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.7161 |
Intermediate Similarity |
NPD4340 |
Discontinued |
0.7161 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7152 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.7152 |
Intermediate Similarity |
NPD1471 |
Phase 3 |
0.7151 |
Intermediate Similarity |
NPD2403 |
Approved |
0.7134 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7133 |
Intermediate Similarity |
NPD5283 |
Phase 1 |
0.7126 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7125 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7124 |
Intermediate Similarity |
NPD7095 |
Approved |
0.7123 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7117 |
Intermediate Similarity |
NPD6273 |
Approved |
0.7115 |
Intermediate Similarity |
NPD6651 |
Approved |
0.7111 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7101 |
Intermediate Similarity |
NPD6971 |
Discontinued |
0.7097 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7097 |
Intermediate Similarity |
NPD3142 |
Approved |
0.7097 |
Intermediate Similarity |
NPD3140 |
Approved |
0.7091 |
Intermediate Similarity |
NPD2649 |
Approved |
0.7091 |
Intermediate Similarity |
NPD2651 |
Approved |
0.7091 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7086 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7081 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7078 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7078 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7062 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7052 |
Intermediate Similarity |
NPD4575 |
Clinical (unspecified phase) |
0.7049 |
Intermediate Similarity |
NPD4413 |
Clinical (unspecified phase) |
0.7047 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7047 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7025 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.7025 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.702 |
Intermediate Similarity |
NPD1876 |
Approved |
0.7012 |
Intermediate Similarity |
NPD5049 |
Phase 3 |
0.7006 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7006 |
Intermediate Similarity |
NPD5089 |
Approved |
0.7006 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7006 |
Intermediate Similarity |
NPD5090 |
Approved |
0.7 |
Intermediate Similarity |
NPD9717 |
Approved |
0.7 |
Intermediate Similarity |
NPD2424 |
Discontinued |
0.7 |
Intermediate Similarity |
NPD4534 |
Discontinued |
0.6988 |
Remote Similarity |
NPD7458 |
Discontinued |
0.6988 |
Remote Similarity |
NPD3455 |
Phase 2 |
0.6982 |
Remote Similarity |
NPD6374 |
Clinical (unspecified phase) |
0.6982 |
Remote Similarity |
NPD5977 |
Approved |
0.6982 |
Remote Similarity |
NPD5978 |
Approved |
0.6982 |
Remote Similarity |
NPD4288 |
Approved |
0.6981 |
Remote Similarity |
NPD2438 |
Suspended |
0.6974 |
Remote Similarity |
NPD2797 |
Approved |
0.6968
|
Remote Similarity |
NPD3764 |
Approved |